SEC Form 4 · accession 0001385508-18-000049

OPIANT PHARMACEUTICALS, INC. · OPNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 4, 2018

Accepted (ET)

Jun 5, 2018 · 4:07 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001385508

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 4, 2018	P	106	$16.50	A	106	D
Common Stock	Jun 4, 2018	P	611	$16.75	A	717	D
Common Stock	Jun 4, 2018	P	100	$16.83	A	817	D
Common Stock	Jun 4, 2018	P	50	$16.28	A	867	D
Common Stock	Jun 4, 2018	P	50	$16.00	A	917	D
Common Stock	Jun 4, 2018	P	200	$16.25	A	1,117	D
Common Stock	Jun 4, 2018	P	195	$16.95	A	1,312	D
Common Stock	Jun 4, 2018	P	286	$16.97	A	1,598	D
Common Stock	Jun 4, 2018	P	100	$15.98	A	1,698	D
Common Stock	Jun 4, 2018	P	100	$16.29	A	1,798	D
Common Stock	Jun 4, 2018	P	200	$16.30	A	1,998	D
Common Stock	Jun 4, 2018	P	6	$16.40	A	2,004	D
Common Stock	Jun 4, 2018	P	200	$16.84	A	2,204	D
Common Stock	Jun 4, 2018	P	100	$16.69	A	2,304	D
Common Stock	Jun 4, 2018	P	100	$16.70	A	2,404	D
Common Stock	Jun 4, 2018	P	100	$16.64	A	2,504	D
Common Stock	Jun 4, 2018	P	100	$16.67	A	2,604	D
Common Stock	Jun 4, 2018	P	100	$16.75	A	2,704	D
Common Stock	Jun 4, 2018	P	300	$16.78	A	3,004	D
Common Stock	Jun 4, 2018	P	100	$16.83	A	3,104	D
Common Stock	Jun 4, 2018	P	194	$16.85	A	3,298	D
Common Stock	Jun 4, 2018	P	105	$16.92	A	3,403	D
Common Stock	Jun 4, 2018	P	200	$16.98	A	3,603	D
Common Stock	Jun 4, 2018	P	200	$16.94	A	3,803	D
Common Stock	Jun 4, 2018	P	200	$16.90	A	4,003	D
Common Stock	Jun 4, 2018	P	997	$15.70	A	5,000	D

No Table II lines on this filing.